BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20551225)

  • 1. Expansion of the target of rapamycin (TOR) kinase family and function in Leishmania shows that TOR3 is required for acidocalcisome biogenesis and animal infectivity.
    Madeira da Silva L; Beverley SM
    Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11965-70. PubMed ID: 20551225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of target of rapamycin signaling by rapamycin in the unicellular green alga Chlamydomonas reinhardtii.
    Crespo JL; Díaz-Troya S; Florencio FJ
    Plant Physiol; 2005 Dec; 139(4):1736-49. PubMed ID: 16299168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans.
    Cruz MC; Cavallo LM; Görlach JM; Cox G; Perfect JR; Cardenas ME; Heitman J
    Mol Cell Biol; 1999 Jun; 19(6):4101-12. PubMed ID: 10330150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast.
    Alarcon CM; Heitman J; Cardenas ME
    Mol Biol Cell; 1999 Aug; 10(8):2531-46. PubMed ID: 10436010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania major CorA-like magnesium transporters play a critical role in parasite development and virulence.
    Zhu Y; Davis A; Smith BJ; Curtis J; Handman E
    Int J Parasitol; 2009 May; 39(6):713-23. PubMed ID: 19136005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of mutants lacking the Golgi UDP-galactose or GDP-mannose transporters establish that phosphoglycans are important for promastigote but not amastigote virulence in Leishmania major.
    Capul AA; Hickerson S; Barron T; Turco SJ; Beverley SM
    Infect Immun; 2007 Sep; 75(9):4629-37. PubMed ID: 17606605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose Transporters and Virulence in
    Feng X; Tran KD; Sanchez MA; Al Mezewghi H; Landfear SM
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30068561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania major MPK7 protein kinase activity inhibits intracellular growth of the pathogenic amastigote stage.
    Morales MA; Pescher P; Späth GF
    Eukaryot Cell; 2010 Jan; 9(1):22-30. PubMed ID: 19801421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fission yeast TOR homolog, tor1+, is required for the response to starvation and other stresses via a conserved serine.
    Weisman R; Choder M
    J Biol Chem; 2001 Mar; 276(10):7027-32. PubMed ID: 11096119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Trypanosomatid Iron Transporter that Regulates Mitochondrial Function Is Required for Leishmania amazonensis Virulence.
    Mittra B; Laranjeira-Silva MF; Perrone Bezerra de Menezes J; Jensen J; Michailowsky V; Andrews NW
    PLoS Pathog; 2016 Jan; 12(1):e1005340. PubMed ID: 26741360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and cloning of Lmairk, a member of the Aurora/Ipl1p protein kinase family, from the human protozoan parasite Leishmania.
    Siman-Tov MM; Ivens AC; Jaffe CL
    Biochim Biophys Acta; 2001 Jun; 1519(3):241-5. PubMed ID: 11418192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection.
    Zhang WW; Matlashewski G
    Mol Microbiol; 2001 Feb; 39(4):935-48. PubMed ID: 11251814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies.
    Späth GF; Lye LF; Segawa H; Turco SJ; Beverley SM
    Infect Immun; 2004 Jun; 72(6):3622-7. PubMed ID: 15155672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a disulfide isomerase protein of Leishmania major as a putative virulence factor.
    Ben Achour Y; Chenik M; Louzir H; Dellagi K
    Infect Immun; 2002 Jul; 70(7):3576-85. PubMed ID: 12065498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligopeptidase B deficient mutants of Leishmania major.
    Munday JC; McLuskey K; Brown E; Coombs GH; Mottram JC
    Mol Biochem Parasitol; 2011 Jan; 175(1):49-57. PubMed ID: 20883728
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Semini G; Paape D; Blume M; Sernee MF; Peres-Alonso D; Calvignac-Spencer S; Döllinger J; Jehle S; Saunders E; McConville MJ; Aebischer T
    mBio; 2020 Jun; 11(3):. PubMed ID: 32487758
    [No Abstract]   [Full Text] [Related]  

  • 17. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation.
    Späth GF; Beverley SM
    Exp Parasitol; 2001 Oct; 99(2):97-103. PubMed ID: 11748963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast.
    Alarcon CM; Cardenas ME; Heitman J
    Genes Dev; 1996 Feb; 10(3):279-88. PubMed ID: 8595879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence without pathology in phosphoglycan-deficient Leishmania major.
    Späth GF; Lye LF; Segawa H; Sacks DL; Turco SJ; Beverley SM
    Science; 2003 Aug; 301(5637):1241-3. PubMed ID: 12947201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted gene deletion of Leishmania major genes encoding developmental stage-specific leishmanolysin (GP63).
    Joshi PB; Sacks DL; Modi G; McMaster WR
    Mol Microbiol; 1998 Feb; 27(3):519-30. PubMed ID: 9489664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.